Bioactivity | Ep300/CREBBP-IN-2 (Example 73) is a potent and orally active Ep300 and CREBBP inhibitor with IC50s of 0.052 and 0.148 μM, respectively. Ep300/CREBBP-IN-2 can be used for the research of cancer[1]. |
Invitro | Ep300/CREBBP-IN-2 (Example 73) 抑制细胞内 H3K27Ac 活性,其 IC50 为 0.070 μM[1]。Ep300/CREBBP-IN-2 (38 nM-10 mM; 3 days) 抑制 LK2 和 TE-8 细胞生长,GI50 分别为 610.15 μM 和 619.505 μM [1]。 Cell Viability Assay[1] Cell Line: |
In Vivo | Ep300/CREBBP-IN-2 (Example 73; 2 mg/kg/day; oral; twice daily for 9 days) 抑制小鼠肿瘤增殖[1]。 Animal Model: |
Name | Ep300/CREBBP-IN-2 |
CAS | 2259641-59-1 |
Formula | C26H27F3N4O4 |
Molar Mass | 516.51 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. NAITO Hiroyuki, et al. EP300 / CREBBP inhibitor. Patent JPWO2018235966A1. |